- Price is above the Trend Line, keeping the weekly tape constructive.
- Price is above Fair Value, showing premium demand versus the model.
- Activity pressure is positive on the latest completed week.
MED
EBS
Week ended 31 Jul 2026
Weekly Investor Report
Medartis Holding AG · Healthcare · Medical Devices
Latest close
87.80 CHF
1.9%
latest week
Weekly setup
Mixed setup
The weekly trend is not active. Price is 5.5% above the Trend Line and sits at 62.0% of its 52-week range. The latest completed week returned 1.9%, after a 2.9% four-week move. The latest news-sentiment score is 50/100. Near-term considerations: volume confirmation is below normal.
Setup score
49
out of 100
Latest Close
87.80 CHF
31 Jul 2026
1W Return
1.9%
latest completed week
4W Return
2.9%
short-term follow-through
12W Return
14.2%
quarterly tape
Trend Breadth
50.0%
26 of 52 weeks active
Volume Ratio
0.7x
vs 13-week average
- The trend backdrop is inactive, so price action has not confirmed a constructive regime.
- Next-week expectancy is negative at 39.89% based on similar historical setup states.
- Activity pressure is weak, so confirmation is not yet broad enough.
- Trend Line remains the key weekly regime level.
- Activity pressure is the gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through
1.9%
Latest completed week; four-week move 2.9%.
Indicator stack
28/98
Trend and activity pressure are weighted against the latest 12-week confirmation window.
Trend backdrop
Active
The trend backdrop defines the current weekly regime.
Patient Capital
Quiet
Activity-pressure buy-signal status for institutional accumulation timing.
Next-Week Expectancy
Negative 39.89%
Historical one-week expectancy contributes to the evidence score when direction is confirmed.
News sentiment
50/100
1 relevant articles in the latest sentiment read.
01 · Price action
Study the full chart
Where price is—and whether the trend supports it
The weekly trend is not active. Price is 5.5% above the Trend Line and sits at 62.0% of its 52-week range. The latest completed week returned 1.9%, after a 2.9% four-week move.
52-week price path
Price vs Trend Line and Fair Value
Price
Trend Line
Fair Value
02 · Volume and demand
Is real participation confirming the move?
Latest weekly volume is 0.7x the 13-week average. Participation is below its recent norm, so price strength is not receiving full volume confirmation.
26-week volume confirmation
Bar height shows volume; colour shows the weekly price direction
6 Feb
13 Feb
20 Feb
27 Feb
6 Mar
13 Mar
20 Mar
27 Mar
3 Apr
10 Apr
17 Apr
24 Apr
1 May
8 May
15 May
22 May
29 May
5 Jun
12 Jun
19 Jun
26 Jun
3 Jul
10 Jul
17 Jul
24 Jul
31 Jul
Up week
Down week
Demand beneath price
Activity pressure and institutional-style signals
These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.
Activity pressure path
Latest 0.4112-week average 0.21
12-week confirmation
Trend active0/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure4/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership0/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.41Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers
No recent accumulation markers. No reversal markers.
03 · Momentum and leadership
Is performance persistent—and is the stock leading?
Performance is 2.9% over four weeks, 14.2% over 12 weeks, and 1.6% over one year. The current trend has remained active for 0 consecutive weeks.
Performance by holding period
Active trend streak0 weeks
Active weeks in one year26
Trend breadth50.0%
Activity pressure vs relative leadership
Activity pressureRelative leadership
Pressure1.00Latest activity-pressure read.
Pressure change370.7%Four-week change in activity pressure.
Leadership-4.43Latest relative-leadership reading.
RS change48.2%Four-week change in relative leadership.
04 · Fundamentals and valuation
Open full factor analysis
What investors are paying for—and the quality behind it
A published fundamentals and factor snapshot is not available for this company.
No published fundamental snapshot is available for this company.
05 · Ownership, options, and sentiment
What other market participants are doing
Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.
Insider activity-
No recent insider transactions are stored for this company.
News sentiment50/100
Weighted news tone is neutral across 1 relevant articles.
0 positive · 1 neutral · 0 negativePatient CapitalQuiet
Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal
06 · Catalysts and risk
What can move the shares—and how volatile the path has been
Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.
Next earnings-No event is currently stored.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-9.9%Distance below the 52-week high.
13-week volatility3.7%Standard deviation of weekly returns.
Weekly gains and losses
Latest 26 completed weeksEach bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.
6 Feb
6 Mar
3 Apr
1 May
29 May
26 Jun
31 Jul
Weeks higher9 of 2615 weeks finished lower.
Best week+8.5%Week of 26 Jun.
Worst week-8.9%Week of 6 Mar.
Latest week+1.9%Week of 31 Jul.
Shape of recent returns
Strong gains5
Modest gains4
Flat weeks2
Modest losses12
Sharp losses3
Recent vol3.7%13-week weekly-return volatility.
Base vol5.1%52-week weekly-return volatility.
Up/down split22/28Count of positive and negative weeks in the 52-week window.
Average skew4.5% / -3.3%Average positive week versus average negative week.
07 · Sector and peer context
Is this stock leading—or simply moving with its group?
Sector and industry breadth distinguish company-specific strength from a broad group move.
SectorCH Healthcare
4-week rank12 / 40
Group average-1.1%
Trend breadth47.5%
Trend47.5%active weekly trend signals
MD62.5%positive activity pressure
RS42.5%positive relative leadership
Four-week leaders
IndustryCH Medical Devices
4-week rank4 / 5
Group average7.0%
Trend breadth20.0%
Trend20.0%active weekly trend signals
MD80.0%positive activity pressure
RS0.0%positive relative leadership
Four-week leaders
08 · Evidence and weekly data
The underlying research record
Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.
Weekly tape46/100
Trend, activity pressure, participation, and risk combine to a 46/100 tape read.
Indicator analysis23/100Latest 12-week confirmation: trend 0/12, activity pressure 4/12, relative leadership 0/12.
Activity pressure 0.41; No reversal markers Next-Week ExpectancyNegative 39.89%Next-week expectancy is negative with a 39.89% historical one-week setup read.
Adds short-term historical context without overriding trend, activity, or relative leadership. Factors50/100No published factor snapshot is available yet.
Patient CapitalQuietActivity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal Sentiment50/100Weighted news tone is neutral across 1 relevant articles.
Medartis Holding AG: Shareholders Board Members Managers and Company Profile | CH0386200239 Insiders50/100No recent insider transaction evidence is stored.
Earnings50/100No stored earnings event is currently attached to this ticker.
| Week | Close | Return | Trend Line | Fair Value | Pressure | Leadership | Volume | Trend |
|---|---|---|---|---|---|---|---|---|
| 31 Jul 2026 | 87.80 CHF | 1.9% | 83.26 CHF | 76.17 CHF | 1.00 | -4.43 | 13.8K | Off |
| 24 Jul 2026 | 86.20 CHF | -3.6% | 83.27 CHF | 76.12 CHF | 1.04 | -6.38 | 19.3K | Off |
| 17 Jul 2026 | 89.40 CHF | -2.0% | 83.32 CHF | 76.09 CHF | 0.91 | -3.35 | 16.5K | Off |
| 10 Jul 2026 | 91.20 CHF | 6.9% | 83.22 CHF | 76.02 CHF | 0.38 | -0.88 | 39.1K | Off |
| 3 Jul 2026 | 85.30 CHF | 6.1% | 83.03 CHF | 75.93 CHF | -0.37 | -8.55 | 23.2K | Off |
| 26 Jun 2026 | 80.40 CHF | 8.5% | 83.22 CHF | 75.87 CHF | -1.00 | -12.45 | 6.3K | Off |
| 19 Jun 2026 | 74.10 CHF | -1.5% | 83.43 CHF | 75.84 CHF | -1.35 | -17.18 | 16.6K | Off |
| 12 Jun 2026 | 75.20 CHF | 0.1% | 83.50 CHF | 75.82 CHF | -1.28 | -15.77 | 8.3K | Off |
| 5 Jun 2026 | 75.10 CHF | -3.5% | 83.47 CHF | 75.82 CHF | -1.16 | -14.08 | 7.3K | Off |
| 29 May 2026 | 77.80 CHF | 1.2% | 83.47 CHF | 75.82 CHF | -1.06 | -12.17 | 23.6K | Off |
| 22 May 2026 | 76.90 CHF | -0.8% | 83.59 CHF | 75.81 CHF | -0.96 | -13.13 | 25.9K | Off |
| 15 May 2026 | 77.50 CHF | 0.8% | 83.68 CHF | 75.78 CHF | -0.99 | -10.76 | 25.7K | Off |
| 8 May 2026 | 76.90 CHF | 0.0% | 83.77 CHF | 75.75 CHF | -0.90 | -10.68 | 18.2K | Off |
| 1 May 2026 | 76.90 CHF | -0.1% | 84.02 CHF | 75.71 CHF | -0.83 | -10.96 | 55.3K | Off |
How to use this report
This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.